Table 4 Acid–base status at start of RCA-CVVHD treatment and end of observation
|  | Normal liver function (bilirubin ≤2 mg/dl) | Mild liver failure (bilirubin 2–7 mg/dl) | Severe liver failure (bilirubin ≥7 mg/dl) | |||
|---|---|---|---|---|---|---|
Start | End | Start | End | Start | End | |
Arterial pH | 7.33 ± 0.10 | 7.41 ± 0.06 | 7.33 ± 0.10 | 7.44 ± 0.05 | 7.35 ± 0.10 | 7.42 ± 0.05 |
Arterial serum bicarbonate (mmol/L) | 20.9 ± 4.8 | 25.2 ± 2.4 | 20.5 ± 5.2 | 25.8 ± 2.0 | 20.8 ± 4.3 | 24.7 ± 2.7 |
Base excess (mmol/L) | −4.1 ± 5.8 | 1.3 ± 3.2 | −4.6 ± 6.3 | 1.4 ± 6.8 | −3.9 ± 5.0 | −0.9 ± 6.8 |
Arterial lactate (mmol/L) | 2.27 ± 3.61 | 1.71 ± 2.22 | 3.78 ± 4.53 | 2.63 ± 3.25 | 2.81 ± 2.69 | 3.41 ± 4.93 |
Arterial pO2 (mmHg) | 101 ± 34 | 96 ± 29 | 99 ± 31 | 92 ± 28 | 93 ± 27 | 96 ± 21 |
Arterial pCO2 (mmHg) | 40 ± 11 | 41 ± 9 | 41 ± 11 | 43 ± 8 | 39 ± 11 | 39 ± 7 |